Betel Nut's Hidden Dangers Spark Global Health Crackdowns

Betel nut, chewed by around 600 million people worldwide, is derived from the Areca catechu palm. While it offers a mild stimulant effect, health authorities warn of serious risks linked to its use, including cancer, dependency, and oral health issues like oral submucous fibrosis and gum irritation. The World Health Organization (WHO) classifies it as a carcinogen, directly linking it to mouth and oesophagus cancers. Regular use can also lead to tooth decay and deep, permanent teeth staining. Furthermore, it may interfere with medications and cause withdrawal symptoms upon cessation. The U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) advise against its consumption due to these health concerns.

Betel nut's energy-boosting and euphoric effects are often cited, but its health benefits remain unproven. Since 2012, the WHO Western Pacific Region has implemented measures to reduce betel nut use, including the Betel Nut Control and Cessation project in Papua New Guinea and the Solomon Islands. Countries like Fiji and Vanuatu have banned sales near schools under national tobacco laws, and awareness campaigns have reinforced these efforts. By treating betel nut as a tobacco-like product under the Framework Convention on Tobacco Control (FCTC), consumption has dropped by 10–20% in targeted areas. Progress reviews up to 2025 credit enforcement, education, and restricted access for the decline in consumption.

Despite clear health warnings, betel nut remains widely used. Its links to cancer, oral diseases, and drug interactions have prompted global control measures. Reduced consumption in some regions shows that regulation and public health campaigns can limit its harm, promoting health equity and insurance.